Q3 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.030 | ||||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
BVXV | BiondVax Pharmaceuticals | 3.62 | 0.00 | 0% | 50.6M |
You can purchase shares of BiondVax Pharmaceuticals (NASDAQ: BVXV) through any online brokerage.
Other companies in BiondVax Pharmaceuticals’s space includes: Opiant Pharmaceuticals (NASDAQ:OPNT), Baudax Bio (NASDAQ:BXRX) and Cumberland (NASDAQ:CPIX).
The latest price target for BiondVax Pharmaceuticals (NASDAQ: BVXV) was reported by Aegis Capital on 2015-06-26. The analyst firm set a price target for 15.00 expecting BVXV to rise to within 12 months (a possible 314.36% upside). 0 analyst firms have reported ratings in the last year.
The stock price for BiondVax Pharmaceuticals (NASDAQ: BVXV) is $3.62 last updated Fri Mar 05 2021 21:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for BiondVax Pharmaceuticals.
There is no upcoming split for BiondVax Pharmaceuticals.